The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
St.Gallen works on the US FDA funded project “RiskSurve” which has just been extended to a second year. The project aims at developing a comprehensive site quality assessment based on machine learning models. Participants will understand how regulators approach site risk assessments and how to use data for risk and non-risk related decision-making.
Speaker(s):
Matteo
BERNASCONI,
Research Associate & PhD Student,
University of St.Gallen